Navigation Links
Global Fund Increases AIDS, Tuberculosis and Malaria Prevention and Treatment Measures by 30-50% Over One Year
Date:7/8/2009

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.3 million people on treatment for HIV/AIDS, 5.4 million people have been treated for tuberculosis, and 88 million insecticide-treated nets have been distributed to prevent malaria infection. In addition, more than 500,000 HIV-positive pregnant women have been treated to prevent their babies from being born with HIV. Over the past year, the number of people accessing ARVs through Global Fund-financed programs has increased by 31%, the number given tuberculosis drugs has increased by 38% and the number of nets distributed has increased by 49%.

These latest results strengthen evidence that investments during the past five years have resulted in the most significant progress ever achieved in the global fight against these three diseases. Recent evidence suggests that global mortality from tuberculosis is now declining, AIDS mortality among adults in several high-burden countries in Africa is declining, and malaria elimination efforts have made tremendous progress, with reductions in the number of cases and malaria-related child mortality falling between 50% and 80% in a growing number of countries.(1) The Global Fund has been a leader in this progress, contributing nearly 25% of global financing for HIV/AIDS and almost two-thirds of the financing for tuberculosis and malaria.

"These impressive results from Global Fund-financed programs are a testament to what the world can do together to fight disease and improve health around the world," said Natasha Bilimoria, Executive Director of Friends of the Global Fight. "Because of strong U.S. leadership and support, the Global Fund is able to partner with countries around the world, improving not only citizens' health but in turn strengthening local and national economies. It's a development tool that continues to be a sound investment and shows real results."

Together, AIDS, tuberculosis and malaria kill about six million people per year. With grants worth $16 billion in 140 countries around the world, the Global Fund has become the world's leading global public health financier.

"In less than eight years, the Global Fund has gone from a concept to a driver of change," said Michel Kazatchkine, Executive Director of the Global Fund. "When we first began our work in 2002, few people in developing countries were being treated for AIDS or tuberculosis. Malaria was a neglected disease. Many countries simply did not have the resources to fight these diseases effectively. Now the story is changing dramatically. There is still much to be done, but we are making real progress and I am proud that the Global Fund is a leader in this global effort."

In 2002, the U.S. government made the founding $200 million pledge to the Global Fund. In FY2009, the U.S. government appropriated $1 billion for the Global Fund, the highest amount contributed to date. Strong support from the U.S. government is a critical component of Global Fund success; every $1 committed by the U.S. is leveraged to generate $2 in contributions from other donors.

"We are at an historic moment in the fight for better health," Bilimoria said. "With Global Fund financing, health and health systems are improving dramatically around the world."

For further details about the Global Fund's prevention and treatment numbers, please see: http://www.theglobalfund.org/en/pressreleases/.

FRIENDS OF THE GLOBAL FIGHT AGAINST AIDS, TUBERCULOSIS AND MALARIA

Friends of the Global Fight works to educate, engage and mobilize American decision makers to support the Global Fund to Fight AIDS, Tuberculosis and Malaria and the fight to end the worldwide burden of these three diseases. For more information about Friends of the Global Fight, visit www.TheGlobalFight.org.

THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA

The Global Fund is a unique global public/private partnership dedicated to attracting and disbursing additional resources to prevent and treat HIV/AIDS, tuberculosis and malaria. This partnership between governments, civil society, the private sector and affected communities represents a new approach to international health financing. The Global Fund works in close collaboration with other bilateral and multilateral organizations to supplement existing efforts dealing with the three diseases.

(1) The Global Fund, "Scaling Up for Impact: Results Report," March 2009. Online at http://www.theglobalfund.org/documents/publications/progressreports/ProgressReport2008_en.pdf.


'/>"/>
SOURCE Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Medforce Technologies, a leading ... the only electronic signature tool built specifically for the healthcare industry by a ... in the modern healthcare company: obtaining signatures from a wide variety of individuals ...
(Date:2/28/2017)... Gowrie, IA (PRWEB) , ... February 28, 2017 , ... Webster-Calhoun Cooperative Telephone Association ... cooperative to be held on Tuesday, March 14th at 7:00 pm at the Southeast Valley ... is "Set Your Sights For Great Service" What do you look for in ...
(Date:2/28/2017)... ... February 28, 2017 , ... Today, Bright Pink , a national ... empowering young women to live proactively at a young age. 1 in 8 ... cancer. Prevention and early detection can save lives-but only if young women are proactive ...
(Date:2/28/2017)... ... February 28, 2017 , ... The American Academy of ... scientific development, healthcare training and clinical application of medical infrared imaging, has announced ... 16-17 in Greenville, SC at the Bon Secours St. Francis Hospital campus at ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... Institute (HCI) announced a new partnership through which HCI students, faculty, and ... curriculum and practices. The partnership also enables the HCI community to receive educational ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... February 28, 2017 The ... rendered the vendor landscape of the  Global Lap ... exhibits a high degree of consolidation with the ... the overall market in 2016. Among these enterprises ... and Abbott Laboratories enjoy dominance on account of ...
(Date:2/28/2017)... Calif., Feb. 28, 2017  Ionis Pharmaceuticals, Inc. (Nasdaq: ... its financial guidance by ending 2016 with pro forma ... cash, cash equivalents and short-term investments. The Company also ... "2016 was a year of significant accomplishments ... in record time and with a very broad label. ...
(Date:2/28/2017)... 28, 2017 ... Research and Markets has announced the addition of the ... to their offering. The latest research Ovarian Cancer Drugs ... in the global Ovarian Cancer market. The research answers the ... marketed for Ovarian Cancer and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: